These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10886532)

  • 1. Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution?
    Schalm SW; van Wijngaarden JK
    J Viral Hepat; 2000 Jul; 7(4):245-9. PubMed ID: 10886532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of hepatitis viruses by surgeons.
    Goodman DB
    N Engl J Med; 1996 Jul; 335(4):284; author reply 285-7. PubMed ID: 8657249
    [No Abstract]   [Full Text] [Related]  

  • 3. What should be done about hepatitis-B-infected health-care workers?
    Carman WF; Cameron SO
    J Med Microbiol; 2003 May; 52(Pt 5):371-372. PubMed ID: 12721310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women].
    Yang S; Liu M; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):329-31. PubMed ID: 18953863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians.
    Lo CM; Fan ST; Lai CL; Liu CL; Yuen MF; Ng IO; Wong J
    Transplant Proc; 1999; 31(1-2):535-6. PubMed ID: 10083224
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 7. Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.
    Buster EH; van der Eijk AA; Schalm SW
    Antiviral Res; 2003 Oct; 60(2):79-85. PubMed ID: 14638402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advance in clinical studies of the kinetics of hepatitis B virus].
    Tang YT; Cao Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B and health-care workers.
    Eddleston AL
    Lancet; 1997 May; 349(9062):1339-40. PubMed ID: 9149693
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lamivudine treatment consensus from relative experts].
    Lamivudine Clinical Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391
    [No Abstract]   [Full Text] [Related]  

  • 11. Focus: Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: to switch or not to switch?
    Shouval D
    J Hepatol; 2012 Jun; 56(6):1219-20. PubMed ID: 22406736
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Gerlich WH
    Intervirology; 2014; 57(3-4):202-11. PubMed ID: 25034489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen.
    Incident Investigation Teams and Others
    N Engl J Med; 1997 Jan; 336(3):178-84. PubMed ID: 8992352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good results of lamivudine in hepatitis B surface antigen-positive patients with active viral replication before liver transplantation.
    Gugenheim J; Baldini E; Ouzan D; Sowka P; Mouiel J
    Transplant Proc; 1999; 31(1-2):554-5. PubMed ID: 10083234
    [No Abstract]   [Full Text] [Related]  

  • 16. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
    Wiegand J; Wedemeyer H; Finger A; Heidrich B; Rosenau J; Michel G; Bock CT; Manns MP; Tillmann HL
    Antivir Ther; 2008; 13(4):547-54. PubMed ID: 18672533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early prediction of lamivudine response in e antigen-negative chronic hepatitis B patients].
    Li JG; Li JX; Liu MX; Qin HQ; Chai YY; Wang XY; Li SF; Tian SW; Zhao LF; Niu Q; Zhang JQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):745-9. PubMed ID: 19874689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of hepatitis B virus from a surgeon to his patients during high-risk and low-risk surgical procedures during 4 years.
    Spijkerman IJ; van Doorn LJ; Janssen MH; Wijkmans CJ; Bilkert-Mooiman MA; Coutinho RA; Weers-Pothoff G
    Infect Control Hosp Epidemiol; 2002 Jun; 23(6):306-12. PubMed ID: 12083233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of de novo hepatitis B virus infections: more seems no better.
    Mutimer D
    Liver Transpl; 2010 Mar; 16(3):256-8. PubMed ID: 20209586
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.